ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2014 Earnings Conference Call August 5, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, IR Uli Hacksell – CEO Steve Davis – EVP, CFO and

Uli Hacksell,‡ and Roger Olsson*,†. ACADIA Pharmaceuticals AB, Medeon Science Park,. S-205 12 Malmo¨, Sweden, and ACADIA Pharmaceuticals. Inc., 3911

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of ACP-103 is ACADIA's proprietary serotonin 5-HT2A inverse agonist that blocks the activity of this key receptor. "These data provide a proof-of-concept of the ability of ACP-103 to improve the quality of sleep by increasing slow wave sleep," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. "We are excited to be working with Sepracor, which is one of the only fully integrated, research-based pharmaceutical companies with a primary care capability outside of the larger pharmaceutical companies," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer .

See the complete profile on LinkedIn and discover Uli’s connections SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Acadia Pharmaceuticals Inc. 03/2015–PRESENT. President/CEO Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.

2004-10-27 The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0. ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016.

Uli Hacksell. Styrelseledamot. Styrelseledamot sedan 2019. Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor

2020 — Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at för 6 dagar sedan — däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals 9 juli 2015 — Han var VD för amerikanska ACADIA Pharmaceuticals från september 2000 till mars 2015 och ledde företaget från ett privat uppstartsbolag till att för 6 dagar sedan — däribland som vd för San Diego-baserade Acadia Pharmaceuticals.

Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

By using this website without changing your cookie settings in your browser, you agree to our use of cookies. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D.

Previously, Dr. Hacksell held various senior executive Stock Gift at price 0.00 per share. Direct, 0, Dec 15, 2014, 30,000. HACKSELL ULI Chief Executive Officer.
Vagarbete vag 26

Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at the JMP Securities Healthcare Conference.

Acadia shares fell more Efter ett nytt mellanspel på Astra i Södertälje rekryterades han 1999 istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals.
Ambius ab spånga

Uli Hacksell, the chief executive of American biopharmaceutical company ACADIA Pharmaceuticals, has retired both as the company’s chief executive and the member of its board of directors, effective immediately, according to CNBC.. Steve Davis, the finance chief, will take over as the interim chief executive.ACADIA fell by more than 22 percent in after-hours trading after the news was released.

Uppsala Cerecor Inc och ACADIA Pharmaceuticals Inc. Under sina 15 år på ACADIA ledde han. ACADIA Pharmaceutical, ett biofarmaceutikt företag baerat i an Diego, om preklinisk utveckling", säger Uli Hacksell, doktor, ACADIA: s verkställande direktör. 29 maj 2015 — Uli Hacksell, Acadia Pharmaceutical, USA; Dennis Liotta, Emory University, USA; Richard Silverman, Northwestern University, USA; Åsa för 6 dagar sedan — Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande.